Article info

Original research
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor

Authors

  1. Correspondence to William L Redmond; william.redmond{at}providence.org
View Full Text

Citation

Curti BD, Koguchi Y, Leidner RS, et al
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor

Publication history

  • Accepted March 8, 2021
  • First published April 9, 2021.
Online issue publication 
April 09, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.